DADaisuke Asano

Daisuke Asano

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Daisuke Asano has a total of 84 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Embryologic tumor location combined with carbohydrate antigen 19-9 stratifies biological risk in resectable pancreatic head cancer

    by Yohei Tabe, Satoshi Matsui, Ken Oh, Daisuke Asano, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Eriko Katsuta, Daisuke Ban

  • Open Access

    The Clinicopathological Characteristics and Prognosis of Cholangiolocarcinoma: A Multicenter Study With a Central Pathology Review

    by Takamichi Ishii, Kenta Makino, Etsuro Hatano, Mina Komuta, Jun Akiba, Yoshihiro Sakamoto, Shun‐Ichi Ariizumi, Goro Honda, Toru Hisaka, Yutaka Takeda, et al.

    Background: Cholangiolocarcinoma (CLC) is a rare liver cancer with ≥ 80% ductular configuration (DC). Given its rarity, its clinicopathological characteristics remain poorly understood, and its status as a distinct disease entity remains controversial. We conducted a nationwide multicenter study with centralized pathological review to investigate the features of CLC. Methods: We included patients with a postoperative diagnosis of CLC at 49 participating institutions (2005–2018). All cases were re‐evaluated by centralized pathology according to the WHO classification. Results: Among 196 re‐evaluated patients, 56 tumors were classified as CLC, 69 as intrahepatic cholangiocarcinoma (iCCA) with < 80% DC, 53 as small‐duct type iCCA with DC, and 16 as mixed small‐ and large‐duct type (SD/LD‐iCCA with DC). CLC showed a low prevalence of viral hepatitis (23.2%), frequent arterial enhancement (83.9%), and characteristic apical EMA positivity. The median overall survival (OS) was 10.8 years, with 5‐ and 10‐year OS rates of 85.0% and 73.7%, respectively, which were significantly better than those of SD/LD‐iCCA with DC. Recurrence occurred in 38.2% of CLC cases with favorable outcomes following surgical resection. Conclusions: CLC exhibits distinct pathological and prognostic features, including favorable long‐term survival, supporting CLC as a distinct clinicopathological entity. Further molecular research is needed to refine the classification. Trial Registration: This study was registered with the UMIN Clinical Trials Registry (UMIN000057919)


  • Open Access

    Three‐Dimensional Reconstruction and Extended Reality in Thoracic Surgery: Japanese Expert Recommendations From the Anatomy on the Border Expert Consensus Meeting

    by Yujin Kudo, Daisuke Asano, Satoshi Kobayashi, Kentato Miura, Toshiya Abe, Kenoki Ohuchida, Mingyon Mun, Kimihiro Shimizu, Hisashi Iwata, Keiichi Akahoshi, et al.

    Introduction: Precise spatial understanding of the bronchovascular tree is essential for anatomical lung resection. Three‐dimensional (3D) reconstruction and extended‐reality (XR) technologies have emerged as tools for preoperative planning, navigation, and education. We aimed to assess the current use and efficacy of 3D and XR technologies in thoracic surgery in Japan and develop expert recommendations. Methods: Two clinical survey questions on the usefulness of 3D imaging in thoracic surgery and that of VR, AR, and MR were sent to 125 certified thoracic surgical centers. PubMed searches targeted thoracic 3D and XR studies, including English‐language randomized, prospective, and retrospective studies, systematic reviews, and meta‐analyses. Draft statements were refined at the Anatomy on the Border Expert Consensus Meeting (Japan Society for Endoscopic Surgery 2024). Results: Fifty of the 125 institutions (40%) responded. 3D imaging was used by 96% of the institutions, and 72% used it in all cases. “Very” or “moderately” useful was reported by 94% of the institutions. Main purposes for using 3D imaging were preoperative simulation (84%) and anatomical understanding (86%); 52% of the institutions used 3D imaging for intraoperative reference. For XR, awareness was moderate, but adoption remained limited (8%). Among respondents, 74% rated its usefulness as uncertain, while only a small proportion found it clearly useful for preoperative simulation, intraoperative localization, and education. Literature search showed that 3D‐planning reduces blood loss, operative time, and complications in segmentectomy, whereas XR studies demonstrated improved nodule localization and workflow efficiency. Conclusions: 3D imaging should be the standard for complex thoracic resections, particularly segmentectomy. XR is a promising tool, with broader deployment expected as its usability improves and cost decreases.

  • Open Access

    Jejunal Loop-Preserving and Mesentery-Sparing Reconstruction after Pancreaticoduodenectomy in a Patient with Prior Total Gastrectomy

    by Rena Mototani, Keiichi Akahoshi, Takaki Furuyama, Daisuke Asano, Yoshiya Ishikawa, Hiroki Ueda, Eriko Katsuta, Daisuke Ban

    INTRODUCTION: Pancreaticoduodenectomy (PD) after a total gastrectomy is technically challenging because the proximal jejunum has already been utilized for an esophagojejunostomy. Consequently, reconstruction after PD requires the use of a more distal jejunal segment, and the optimal reconstruction strategy remains controversial. We report a case of a jejunal loop-preserving and mesentery-sparing reconstruction after PD in a patient with a prior total gastrectomy.CASE PRESENTATION: A 70-year-old man with a history of Roux-en-Y total gastrectomy for gastric cancer presented with obstructive jaundice. Imaging studies demonstrated a periampullary tumor with suspected regional lymph node metastasis, and ampullary carcinoma was diagnosed. A PD was performed through an upper midline laparotomy. Following the resection of the pancreatic head and proximal jejunum, reconstruction was achieved using the pre-existing Roux limb without additional mesenteric division. Pancreaticojejunostomy and hepaticojejunostomy were performed using a distal jejunal segment, followed by a side-to-side jejunojejunostomy that preserved jejunal continuity and mesenteric integrity. The operative time was 459 minutes, and blood loss was 603 mL. The postoperative course was uneventful, and the patient was discharged on POD 21. Histopathological examination confirmed adenocarcinoma of the ampulla of Vater (pT3bN1M0, Stage IIIA) with negative surgical margins.CONCLUSIONS: This jejunal loop-preserving and mesentery-sparing reconstruction avoided additional jejunal transection and mesenteric dissection while maintaining the continuity of the jejunal loop. The technique may represent a simple and anatomically reasonable alternative to conventional double Roux-en-Y reconstruction in selected patients undergoing PD after a total gastrectomy.

  • Open Access

    Comparative analysis of streptozocin-based regimen and capecitabine–temozolomide therapy in advanced pancreatic neuroendocrine neoplasms: influence of tumor grade and Ki-67 index

    by Yohei Tabe, Hiroaki Ono, Satoshi Matsui, Daisuke Asano, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Eriko Katsuta, Daisuke Ban

    Background: Systemic therapy is a standard treatment option for pancreatic neuroendocrine neoplasms (Pan-NENs) with unresectable or metastatic disease. Streptozocin (STZ)-based chemotherapy is considered a standard treatment option for tumors with a high Ki-67 index or for cases refractory to molecular targeted agents. More recently, the combination of capecitabine and temozolomide (CAPTEM) therapy has emerged as a new treatment option. Objectives: This study aimed to compare the efficacy, safety, and clinical outcomes between the STZ-based regimen and CAPTEM therapy in patients with unresectable or metastatic Pan-NENs. Design: This was a single-center retrospective study of histologically confirmed Pan-neuroendocrine tumor (NET) patients treated with either STZ-based regimens or CAPTEM between November 2015 and June 2024. Methods: We compared efficacy, safety, and clinical outcomes between the two regimens. Tumor responses were assessed using Response Evaluation Criteria in Solid Tumors version 1.1, and adverse events were graded according to Common Terminology Criteria for Adverse Events version 5.0. The study was conducted in compliance with the STROBE guidelines. Results: Of the 371 patients diagnosed with Pan-NENs, 47 received STZ-based regimen and 21 received CAPTEM therapy. In the NET-G1/G2 patients, the STZ group showed a significantly higher tumor shrinkage rate compared to CAPTEM therapy. Although no significant differences were observed in progression-free survival (PFS) or overall survival between the two groups, subgroup analysis showed that the median PFS in the STZ group was significantly longer than that in the CAPTEM group in NET G1/G2 patients. Renal dysfunction was the main adverse event in the STZ regimen group, while gastrointestinal symptoms were common in the CAPTEM therapy group; however, both were manageable. Conclusion: Both STZ-based regimen and CAPTEM therapy are safe and effective treatment options for advanced Pan-NENs. STZ-based regimen was more beneficial in NET-G1/G2 patients, suggesting Ki-67 index and tumor grade may serve as indicators for treatment selection. Further prospective studies are warranted to validate these findings.


  • Open Access

    Indications for Surgical Resection in Patients With Neuroendocrine Tumor Liver Metastases: An Intensive Surgical Experience of a High‐Volume Center

    by Daisuke Asano, Toshitaka Sugawara, Keiichi Akahoshi, Shotaro Gan, Shohei Motohashi, Shuichi Watanabe, Yoshiya Ishikawa, Hiroki Ueda, Atsushi Kudo, Daisuke Ban

    Background: Surgical resection for neuroendocrine liver metastasis (NELM) is the key to long survival; however, the indications remain unclear due to the high recurrence rate. We aimed to identify candidates who would benefit from surgical resection for NELM. Methods: Patients with NELM treated at our institution from January 2005 to December 2020 were included. Neuroendocrine carcinoma (NEC) was excluded. Risk factors for overall survival (OS) and recurrence‐free survival (RFS) were analyzed. The cut‐off value for the number of NELM predicting poor RFS was determined by minimum p ‐value approach. Results: Of the total 126 patients, 67 patients underwent liver resection. The median follow‐up time from the date of initial diagnosis of NELM was 4.3 years. Surgical resection and NET‐G1/2 were associated with good OS in multivariate analysis ( p < 0.001). In patients underwent R0/1 resection ( n = 44), NET‐G3 [HR: 3.1 (95% CI 1.4–7.2)] and the number of NELM [HR: 1.1 (95% CI 1.0–1.1)] were associated with poor RFS in multivariate analysis. The optimal cut‐off value for the number of NELM was calculated as 8. The median RFS for patients with 8 or more liver metastases or NET‐G3 was 3.9 months, which was extremely short compared to patients with NET‐G1/2 (13.8 months) and to those who had fewer than 8 liver metastases (19.1 months). Conclusion: This study suggests that fewer than 8 liver metastases and NET‐G1/2 are indications for surgical resection in patients with NELM considering the RFS. Surgical resection for patients with 8 or more liver metastases or NET‐G3 needs deliberate selection.

  • Open Access

    Based on the results of a large retrospective study comparing laparoscopic liver surgery and robotic liver surgery, is it time for the next step in robotic liver resection?

    by Daisuke Asano, Daisuke Ban

    Based on the results of a large retrospective study comparing laparoscopic liver surgery and robotic liver surgery, is it time for the next step in robotic liver resection?


  • Open Access

    A Case of Curative Resection by Minimally Invasive Surgery in Two Stages Using the Hormonal Mapping Test for Pancreatic Head ACTHoma with Multiple Liver Metastases

    by Shohei Motohashi, Daisuke Asano, Satoshi Matsui, Yoshiya Ishikawa, Hiroki Ueda, Keiichi Akahoshi, Eriko Katsuta, Daisuke Ban

    INTRODUCTION: Symptom control is sometimes as important as tumor burden control in patients with functional neuroendocrine tumors (NETs). The selective arterial calcium injection (SACI) test is widely used to localize functional NETs, particularly insulinomas and gastrinomas; however, its utility in adrenocorticotropic hormone (ACTH)-producing tumors (ACTHomas) remains unclear. We present a case of a pancreatic head ACTHoma with synchronous liver metastases in which the SACI test with venous sampling (“hormonal mapping”) enabled a safe, staged curative resection.CASE PRESENTATION: A 42-year-old woman presented with features of Cushing’s syndrome, including edema and weight gain. CT revealed a pancreatic head tumor with multiple liver metastases. Liver biopsy confirmed the diagnosis of NET, suggesting an ACTHoma. Hormonal mapping demonstrated that liver metastases, rather than the pancreatic tumor, were the predominant sources of ACTH secretion. To achieve hormonal control, we prioritized laparoscopic liver resection, followed by laparoscopic pancreatoduodenectomy three months later after confirming the absence of new metastatic lesions. At 21 months postoperatively, the patient remains recurrence-free.CONCLUSIONS: Hormonal mapping was effective in identifying hormone-producing lesions and guiding surgical strategies for ACTHomas with liver metastases.

  • Open Access

    Anatomy on the Border Expert Consensus Meeting: Current Status and Future Perspectives of Three‐Dimensional Image Reconstruction and Immersive Technologies in Liver Surgery

    by Daisuke Asano, Yujin Kudo, Satoshi Kobayashi, Toshiya Abe, Kenoki Ohuchida, Keiichi Akahoshi, Go Wakabayashi, Kimihiro Shimizu, Mingyon Mun, Hisashi Iwata, et al.

    Introduction: The Japan Society for Endoscopic Surgery organized the Anatomy on the Border Expert Consensus Meeting in 2024 to foster cross‐disciplinary discussions. One of the themes, on parenchymal organs, brought together liver, lung, and kidney specialists to jointly discuss the current status and future perspectives of three‐dimensional image reconstruction and augmented/virtual/mixed reality technologies in surgery. This report summarizes the results of these discussions in relation to liver surgery. Methods: A questionnaire was distributed to board‐certified expert training facilities of the Japanese Society of Hepato‐Biliary‐Pancreatic Surgery and liver surgeons certified by the Japan Society for Endoscopic Surgery. A systematic review of English language articles published between 2015 and 2024 was also conducted. Results: Responses were obtained from 86 institutions. The majority (88%) reported routine use of three‐dimensional image reconstruction, mainly for preoperative planning (92%) and anatomical understanding (88%). It was rated as very or moderately useful by 99% of respondents. A literature review confirmed the perioperative benefits of this technique. In contrast, augmented/virtual/mixed reality technologies were used in only 16% of the institutions; the majority of these (79%) acknowledged their usefulness, primarily for anatomical understanding and education. The barriers to implementation included cost and data preparation complexity. The educational benefits were supported by data from randomized controlled trials; however, clinical evidence remains limited and inconsistent. Conclusion: Three‐dimensional image reconstruction has become essential in liver surgery. Augmented/virtual/mixed reality technologies, although in the early stages, show promise for surgical education and may eventually contribute to surgical practice as accessibility improves.

  • Open Access

    Clinical Practice and Survey of Three‐Dimensional Images, Virtual Reality, Augmented Reality and Mixed Reality for Robotic‐Assisted Surgery in Urology—“Anatomy on the Border” Expert Consensus Meeting

    by Satoshi Kobayashi, Daisuke Asano, Yujin Kudo, Shintaro Narita, Shuichi Morizane, Toshiya Abe, Kenoki Ohuchida, Tomonori Habuchi, Atsushi Takenaka, Go Wakabayashi, et al.

    Background and Objectives: There have been no nationwide surveys on the effectiveness of 3D images, virtual reality (VR), augmented reality (AR), and mixed reality (MR) in robotic‐assisted surgery for urology. This study aimed to conduct a nationwide survey of techniques for laparoscopic and robotic 3D images, VR, AR, and MR in urology, and to propose a consensus on their effectiveness. Material and Methods: In July 2024, the Japan Society for Endoscopic Surgery conducted an anonymous online survey to evaluate the effectiveness of 3D images, VR, AR, and MR among 44 certified laparoscopic technicians and qualified proctors in robotic surgery. Results: Thirty‐two urologists surveyed reported using 3D imaging for preoperative evaluation (84%) and to understand anatomy (75%), with 97% reporting clinical benefits and 85% indicating that it improved the quality of surgery. This widespread usage and the reported benefits of 3D imaging in urology should reassure the audience about the effectiveness of this technology. VR/AR/MR were primarily used for simulation (19%) and navigation (16%). While 63% expressed interest in these technologies, 51% reported never having used them. Among the barriers to adoption, 25% cited high cost, 24% cited the effort required for data processing, and 14% cited the difficulty of use. Conclusion: 3D images and VR/AR/MR technologies were expected to play a pivotal role in urological robotic surgery. These technologies have the potential to enhance precision and improve outcomes significantly. This study provided a comprehensive overview of the current usage status and challenges associated with these techniques.